Travere Therapeutics Inc (NASDAQ:TVTX)

27.99
Delayed Data
As of 4:00pm ET
 -0.51 / -1.79%
Today’s Change
12.75
Today|||52-Week Range
33.09
+2.70%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$1.8B

Company Description

Travere Therapeutics, Inc. is a biopharmaceutical company. It engages in the identification, development, commercialization, and distribution of therapies to people living with rare diseases. The firm's products include Chenodal, Cholbam, and Thiola. The company was founded by Martin Shkreli on February 8, 2008 and is headquartered in San Diego, CA.

Contact Information

Travere Therapeutics, Inc.
3611 Valley Centre Drive
San Diego California 92130
P:(888) 969-7879
Investor Relations:
(646) 564-3680

Employees

Shareholders

Other institutional66.05%
Mutual fund holders35.99%
Individual stakeholders1.20%

Top Executives

Eric M. DubePresident, Chief Executive Officer & Director
Laura M. ClagueChief Financial Officer
Bill RoteSenior VP, Head-Research & Development
Noah L. RosenbergChief Medical Officer
Elizabeth E. ReedSecretary, Senior Vice President & General Counsel